STOCK TITAN
  1. Home
  2. Sec-filings
  3. ADIL
  4. [EFFECT] ADIAL PHARMACEUTICALS, INC. SEC Filing

[EFFECT] ADIAL PHARMACEUTICALS, INC. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 17, 2025 4:00 P.M.
Form: S-3
CIK: 0001513525
Company Name: ADIAL PHARMACEUTICALS, INC.
File Number: 333-292110

Source: View Original Filing on SEC EDGAR

Stock ADIL logo
Adial Pharmaceuticals Inc

NASDAQ:ADIL

ADIL Rankings

#6463 Ranked by Market Cap
N/A Ranked by Dividends

ADIL Latest News

Nov 26, 2025
Adial Pharmaceuticals Announces a Warrant Inducement Transaction for Approximately $2.86 Million in Gross Proceeds
Nov 14, 2025
Adial Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
Oct 17, 2025
Adial Pharmaceuticals CEO was a Featured Guest on The Big Biz Show
Oct 9, 2025
Adial Pharmaceuticals Partners with Genomind for Precision Medicine Testing Solution
Sep 16, 2025
Adial Pharmaceuticals Provides Business Update Following Favorable Comments from FDA End-of-Phase 2 (EOP2) Meeting for AD04

ADIL Latest SEC Filings

Dec 12, 2025
[S-3] ADIAL PHARMACEUTICALS, INC. Shelf Registration Statement
Nov 14, 2025
[8-K] ADIAL PHARMACEUTICALS, INC. Reports Material Event
Nov 13, 2025
[10-Q] ADIAL PHARMACEUTICALS, INC. Quarterly Earnings Report
Sep 16, 2025
[8-K] ADIAL PHARMACEUTICALS, INC. Reports Material Event
Sep 9, 2025
[S-8] Adial Pharmaceuticals, Inc Employee Benefit Plan Registration

ADIL Stock Data

6.98M
23.45M
2.47%
2.62%
6.55%
Biotechnology
Pharmaceutical Preparations
Link
United States
CHARLOTTESVILLE